Price Target Increase#
Keefe, Bruyette & Woods has raised its price target for Chemung Financial stock (NASDAQ:CHMG) from $64 to $72, while keeping a Market Perform rating. This adjustment comes after the company reported strong quarterly results that exceeded expectations.
Strong Quarterly Results#
Chemung Financial's pre-provision net revenue beat estimates by $0.25. Additionally, the company saw a 3% increase in end-of-period loans compared to the previous quarter. Although the net interest margin—a measure of profitability—declined by 1 basis point, it still surpassed the firm's estimates by 6 basis points. The stock has experienced a significant rise, increasing 15% in the past week and 65% over the last year, currently trading at $67.95.
Financial Health and Valuation#
The firm noted that the provision results were better than expected, with non-performing assets rising slightly to 0.42%, which remains low. Keefe, Bruyette & Woods has also raised its earnings estimates for 2026 by 7% and for 2027 by 1%. The shares are currently trading at 8.4 times the estimated earnings for 2027 and 1.3 times the tangible book value per share. Despite what they describe as an attractive valuation, the firm maintains its Market Perform rating.
Strategic Developments#
In recent news, Chemung Financial Corporation is working on converting its subsidiary, Chemung Canal Trust Company, from a New York chartered trust company to a national bank, pending approval from the Office of the Comptroller of the Currency. Furthermore, the Board of Directors has approved a quarterly cash dividend of $0.34 per share, set to be paid on April 1, 2026, to shareholders recorded by March 18, 2026. These steps indicate the company's commitment to strategic growth and financial stability.